
New drug offers hope to patients with asbestos-related cancer
The NERO clinical trial results were presented at the American Association of Cancer Research conference on Tuesday, April 29. The findings bring new hope for mesothelioma patients whose cancer has returned after initial treatment. The trial was conducted …